Other studies with hypopharynx cancers suggest that ZNF154 has tumour-suppressive action by inhibiting the Wnt/β-catenin signalling pathway activation and suppressing epithelial-mesenchymal transition [20]. The gene discussed is ZNF154; the disease is cancer.